Free Trial

Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $55.00 by Analysts at KeyCorp

Acadia Healthcare logo with Medical background

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price objective reduced by equities researchers at KeyCorp from $65.00 to $55.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. KeyCorp's price objective indicates a potential upside of 104.16% from the stock's current price.

Other analysts also recently issued research reports about the company. Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Barclays lowered Acadia Healthcare from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $43.00 to $35.00 in a report on Friday, February 28th. Guggenheim initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective on the stock. Mizuho dropped their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating on the stock in a report on Tuesday, March 25th. Finally, Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $49.28.

Check Out Our Latest Stock Analysis on ACHC

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC opened at $26.94 on Wednesday. The stock has a market capitalization of $2.48 billion, a P/E ratio of 8.83, a P/E/G ratio of 1.46 and a beta of 1.01. The firm's 50-day moving average price is $26.43 and its two-hundred day moving average price is $36.08. Acadia Healthcare has a 52-week low of $20.36 and a 52-week high of $82.41. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. During the same quarter in the previous year, the firm posted $0.84 EPS. The business's revenue for the quarter was up .3% compared to the same quarter last year. As a group, sell-side analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently bought and sold shares of the stock. Lindbrook Capital LLC boosted its stake in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. grew its position in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after acquiring an additional 345 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC raised its position in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after purchasing an additional 1,234 shares in the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines